Afeyan Noubar's Form 4 filing
Omega Therapeutics, Inc. (OMGA) · filed Aug 5, 2021
- Accession no.
- 0000899243-21-031796
- Filed
- Aug 5, 2021, 5:41 PM ET
- Trade date
- Aug 3, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 9 non-derivative transactions and 11 derivative transactions. Open-market purchases total $20.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Afeyan NoubarCIK 0001222012 | Director, 10% Owner |
| Flagship Pioneering, LLCCIK 0001400240 | 10% Owner |
| Flagship Pioneering Fund VI, L.P.CIK 0001716926 | 10% Owner |
| Flagship Pioneering Fund VI General Partner LLCCIK 0001724957 | 10% Owner |
| Flagship Pioneering Special Opportunities Fund II, L.P.CIK 0001761283 | 10% Owner |
| Nutritional Health LTP Fund General Partner LLCCIK 0001780951 | 10% Owner |
| Nutritional Health LTP Fund, L.P.CIK 0001780956 | 10% Owner |
| Flagship Pioneering Special Opportunities Fund II General Partner LLCCIK 0001826217 | 10% Owner |
| FPN General Partner LLCCIK 0001860059 | 10% Owner |
| FPN, L.P.CIK 0001860062 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 | Common Stock | CConversionAcquired | +1,088,470 | – | – | 1,088,470 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionAcquired | +5,896,386 | – | – | 5,896,386 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionAcquired | +8,396,825 | – | – | 8,396,825 | Indirect | |
| Aug 3, 2021 | Common Stock | PPurchaseAcquired | +220,588 | $17.00 | +$3,749,996 | 8,617,413 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionAcquired | +970,588 | – | – | 970,588 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionAcquired | +4,852,943 | – | – | 4,852,943 | Indirect | |
| Aug 3, 2021 | Common Stock | PPurchaseAcquired | +661,764 | $17.00 | +$11,249,988 | 5,514,707 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionAcquired | +1,323,529 | – | – | 1,323,529 | Indirect | |
| Aug 3, 2021 | Common Stock | PPurchaseAcquired | +294,117 | $17.00 | +$4,999,989 | 1,617,646 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 | Common Stock | CConversionDisposed | −1,088,470 | – | – | 0 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionDisposed | −5,896,386 | – | – | 0 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionDisposed | −7,249,767 | – | – | 0 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionDisposed | −794,118 | – | – | 0 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionDisposed | −705,882 | – | – | 0 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionDisposed | −176,470 | – | – | 0 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionDisposed | −3,529,413 | – | – | 0 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionDisposed | −882,353 | – | – | 0 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionDisposed | −441,176 | – | – | 0 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionDisposed | −1,323,530 | – | – | 0 | Indirect | |
| Aug 3, 2021 | Common Stock | CConversionDisposed | −441,176 | – | – | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.